BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17084562)

  • 21. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
    Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
    Antonini N; Jones H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Jager J; Hoogenraad W; Collette L; Pierart M; Hart G; Bartelink H
    Radiother Oncol; 2007 Mar; 82(3):265-71. PubMed ID: 17126434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays.
    Blank E; Kraus-Tiefenbacher U; Welzel G; Keller A; Bohrer M; Sütterlin M; Wenz F
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():352-8. PubMed ID: 20853058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.
    Holli K; Hietanen P; Saaristo R; Huhtala H; Hakama M; Joensuu H
    J Clin Oncol; 2009 Feb; 27(6):927-32. PubMed ID: 19114687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.
    Lemanski C; Azria D; Gourgon-Bourgade S; Gutowski M; Rouanet P; Saint-Aubert B; Ailleres N; Fenoglietto P; Dubois JB
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):698-703. PubMed ID: 19467579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
    Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
    Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
    Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K
    Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
    Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
    Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results.
    Beal K; McCormick B; Zelefsky MJ; Borgen P; Fey J; Goldberg J; Cohen GN; Sacchini V
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):19-24. PubMed ID: 17446003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Audit of local recurrence rates following 'ultra'-conservative surgery for invasive breast cancer--a boost to the breast?
    Cota AM; Humphreys S; Schofield J; Sever A; Jones S; Pickering D; Jones PA
    Breast; 2005 Jun; 14(3):224-9. PubMed ID: 15927831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modelling of radiotherapy strategies for early breast cancer.
    Enderling H; Anderson AR; Chaplain MA; Munro AJ; Vaidya JS
    J Theor Biol; 2006 Jul; 241(1):158-71. PubMed ID: 16386275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
    Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
    Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
    Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. True local recurrence rate in the conserved breast after magnetic resonance imaging-targeted radiotherapy.
    Whipp E; Beresford M; Sawyer E; Halliwell M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):984-90. PubMed ID: 19577866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.